We are guided and inspired by

our vision

About Royal Philips


Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Business highlights in Q2

Philips launches new cardiac ultrasound solutions with anatomical intelligence

Broadening its leading portfolio of power toothbrushes, Philip launched Sonicare DailyClean, an entry-level proposition to address lower price segments, and Sonicare ExpertClean, a high-end range featuring premium brush heads, connectivity and design, in the US.

Safety and efficacy of Philips’ Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trials at three years

Philips results in Q3 2015

Philips in Q2 2019

Sales: 4.7 bln

Adjusted EBITA: 549 mln

Income from continuing operations: 260 mln

Our transition towards a circular economy

Rethink the future

Changing the way we do business
Circular economy activities on Guardian Sustainable Business

Circular economy

Philips' transition to a circular economy
Annual report 2016

Annual Report 2018

Philips announcing its performance of 2018